Loading...
XNYS
MCK
Market cap101bUSD
Dec 04, Last price  
814.18USD
1D
1.09%
1Q
18.44%
Jan 2017
479.69%
Name

Mckesson Corp

Chart & Performance

D1W1MN
XNYS:MCK chart
P/E
30.89
P/S
0.28
EPS
26.36
Div Yield, %
0.24%
Shrs. gr., 5y
-6.78%
Rev. gr., 5y
9.22%
Revenues
359.05b
+16.22%
88,050,000,00092,977,000,000101,703,000,000106,632,000,000108,702,000,000112,084,000,000122,734,000,000122,455,000,000137,609,000,000179,045,000,000190,884,000,000198,533,000,000208,357,000,000214,319,000,000231,051,000,000238,228,000,000263,966,000,000276,711,000,000308,951,000,000359,051,000,000
Net income
3.30b
+9.76%
751,000,000913,000,000990,000,000823,000,0001,263,000,0001,202,000,0001,403,000,0001,338,000,0001,263,000,0001,476,000,0002,258,000,0005,070,000,00067,000,00034,000,000900,000,000-4,339,000,0001,114,000,0003,560,000,0003,002,000,0003,295,000,000
CFO
6.09b
+41.05%
2,744,000,0001,539,000,000869,000,0001,351,000,0002,316,000,0002,338,000,0002,950,000,0002,483,000,0003,136,000,0003,112,000,0003,672,000,0004,744,000,0004,345,000,0004,036,000,0004,374,000,0004,542,000,0004,434,000,0005,159,000,0004,314,000,0006,085,000,000
Dividend
Aug 30, 20240.71 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
IPO date
Nov 10, 1994
Employees
45,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT